MDM2-p53:

Manman Han1, Mohibullah Kakar2, Wei Li3

  • 1Department of General Surgery, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Zhejiang Province, China.

Bioorganic chemistry
|July 11, 2024
PubMed
概括

研究人员确定了针对MDM2蛋白的受体抑制剂,以治疗质母细胞瘤 (GBM). 这些显示稳定的结合,提供了一个有前途的治疗策略,潜在的副作用比传统药物更少.